Table 3.
Geometric mean concentration of anti‐PCP IgG, IgG2, IgA, and IgM in 8 patients with multiple myeloma pre‐ and post‐autologous stem cell transplantation and in 15 patients after vaccination and several months later
| IgG (mg/L) | IgG2 (mg/L) | IgA (U/mL) | IgM (U/mL) | |
|---|---|---|---|---|
| ASCT | ||||
| Pre | 110.5 | 52.74 | 26.32 | 28.8 |
| Post | 14 | 7.8 | 2.97 | 3.7 |
| Fold decrease | 7.9 | 6.8 | 12.9 | 7.7 |
| P | 0.008 | 0.008 | 0.008 | 0.008 |
| No ASCT | ||||
| Postvaccination | 95.47 | 48.76 | 32.77 | 34.57 |
| Late postvaccination | 34.34 | 17.10 | 4.13 | 8.48 |
| Fold decrease | 2.8 | 2.9 | 7.9 | 4.1 |
| P | 0.001 | 0.002 | 0.04 | 6.10 e‐5 |
| ASCT vs no ASCT | ||||
| P | 0.03 | 0.03 | 0.27 | 0.64 |